We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
The National Treatment Agency for Substance Misuse (NTA) was established in 2001 to improve the availability, capacity and effectiveness of drug treatment. It became part of Public Health England in 2013.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
As a result of the public service pensions remedy (known as McCloud), members may have changes to the amount of, or a new unauthorised payment.
How to minimise the risk of disease from animal wool and hair, register your site, and dispose of materials you don't want.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
Treatment forms (T1 to T6) for use in connection with patients detained under the Mental Health Act 1983, who are in receipt of treatment for a mental disorder.
The T27 exemption allows organophosphate sheep dip to be treated with an approved organophosphate-degrading enzyme. T27 is currently unavailable for use.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
For waste operators and exporters classifying some waste electrical and electronic equipment (WEEE) devices, waste components, and wastes from their treatment.
The T32 exemption allows you to treat non-hazardous pesticide washings in a biobed or biofilter.
Licences and authorisations to import genetic material, research and diagnostic samples, trade samples and display items, and some live animals and animal products.
Guidance on referring alcohol dependent patients from hospital to specialist alcohol treatment in the hospital or in the community.
The T29 exemption allows you to treat non-hazardous pesticide washings before disposing of them to land.
Retrospective cohort study of all TB patients registered in the National Tuberculosis programme between 2006 and 2010
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Studies in industrialised and resource-poor countries point to a higher risk of death in TB survivors
Dashboard monitoring hepatitis C virus (HCV) testing and treatment in HCV Operational Delivery Networks (ODNs) in England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).